Literature DB >> 29097512

New Insights into Cardiac and Vascular Natriuretic Peptides: Findings from Young Adults Born with Very Low Birth Weight.

Timothy C R Prickett1, Brian A Darlow2, Richard W Troughton3, Vicky A Cameron3, John M Elliott3, Julia Martin2, L John Horwood4, Eric A Espiner3.   

Abstract

BACKGROUND: In community studies, plasma B-type natriuretic peptide (BNP) is positively associated with cardiovascular disorders. Those born with very low birth weight (VLBW) have increased risk of metabolic and vascular disorders in later life, but plasma concentrations of natriuretic peptides have not been studied. The objectives here were to evaluate BNP and C-type natriuretic peptide (CNP)-a putative marker of vascular risk-in young adults born with VLBW.
METHODS: In all, 220 VLBW cases and 97 matched controls were studied 28 years after birth during a 2-day period at 1 research center. Aminoterminal (NT) products (NTproBNP, NTproCNP) and a range of conventional vascular risk factors including echocardiographic indices were measured along with genetic polymorphisms known to increase plasma NTproBNP.
RESULTS: VLBW individuals were smaller, had smaller hearts, reduced stroke volume and endothelial function, and higher systolic blood pressure and arterial elastance. Of the many humoral vascular and metabolic risk factors measured, including NTproBNP, only plasma NTproCNP (higher in VLBW individuals) differed significantly. Across all individuals, associations of NTproCNP with each of 7 conventional risk factors, as well as with arterial elastance, were positive, whereas associations of NTproBNP with risk were all inverse. In multivariate analysis, the genetic variant rs198358 was independently associated with NTproBNP.
CONCLUSIONS: In young adults at increased risk of cardiovascular disease, higher NTproCNP likely reflects a compensatory vascular response to vascular stress, whereas the negative link with NTproBNP likely reflects beneficial genetic mutations. The ratio of NTproBNP to NTproCNP may provide a novel index of ideal cardiovascular health.
© 2017 American Association for Clinical Chemistry.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29097512     DOI: 10.1373/clinchem.2017.280354

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  Effect of statin therapy on plasma C-type Natriuretic Peptides and Endothelin-1 in males with and without symptomatic coronary artery disease.

Authors:  Timothy C R Prickett; Richard W Troughton; Eric A Espiner
Journal:  Sci Rep       Date:  2020-05-13       Impact factor: 4.379

Review 2.  Circulating Cardiac Biomarkers in Diabetes Mellitus: A New Dawn for Risk Stratification-A Narrative Review.

Authors:  Alexander E Berezin; Alexander A Berezin
Journal:  Diabetes Ther       Date:  2020-05-19       Impact factor: 2.945

3.  Little evidence for long-term harm from antenatal corticosteroids in a population-based very low birthweight young adult cohort.

Authors:  Brian A Darlow; Sarah L Harris; L John Horwood
Journal:  Paediatr Perinat Epidemiol       Date:  2022-05-16       Impact factor: 3.103

4.  Prenatal Particulate Matter (PM) Exposure and Natriuretic Peptides in Newborns from Mexico City.

Authors:  Abigail Muñoz-Rodríguez; Jorge Alfonso Maciel-Ruiz; Ana María Salazar; Monserrat Sordo; Patricia Ostrosky-Wegman; Jorge H Limón-Pacheco; Andrés Eduardo Nepomuceno-Hernández; Rodrigo Ayala-Yáñez; María Eugenia Gonsebatt; Citlalli Osorio-Yáñez
Journal:  Int J Environ Res Public Health       Date:  2021-06-18       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.